Biotech · Private company
Cadent Therapeutics
Track this companyFree. Adds Cadent Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- CAD-1883Phase 2 · Essential TremorClinicalTrials.gov · fetched Nov 12, 2026
- CAD-1883Phase 2 · Spinocerebellar AtaxiasClinicalTrials.gov · fetched Nov 12, 2026
- CAD-9303Phase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of CAD-1883 for Spinocerebellar AtaxiaPHASE2 · WITHDRAWN · started Jun 1, 2021ClinicalTrials.gov NCT04301284 · fetched Nov 12, 2026
- Study of CAD-9303 in Subjects With SchizophreniaPHASE1 · COMPLETED · started Feb 28, 2020ClinicalTrials.gov NCT04306146 · fetched Nov 12, 2026
- A Clinical Study to Evaluate CAD-1883 in Essential TremorPHASE2 · COMPLETED · started Jan 23, 2019ClinicalTrials.gov NCT03688685 · fetched Nov 12, 2026